Association of baseline LDL-C with total and cardiovascular mortality in patients using proprotein convertase subtilisin-kexin type 9 inhibitors: A systematic review and meta-analysis.

What moved togetherboth groups pooled, not the treatment’s effect

Correlation · may be no link

−6%−19% to +9%

Bigger than 2 in 10 for all-cause mortality

As reported

RR 0.94, 95% CI 0.81–1.09 · the paper's word: All-cause mortality

the abstract, start to end

… all-cause mortality (relative risk [RR], 0.94, 95% confidence interval [CI], …

← favours treatmentfavours comparator →

could be chance

All-cause mortality

RR 0.940.81–1.09

PCSK9 inhibitorsAll-cause mortality

1 / 3

2019

2020

2021

2022

2023

2024

2025

2026

pooled ittrialcites it